Oramed Pharmaceuticals Inc. Stock Prediction
AI-powered sentiment analysis and prediction trends for ORMP, updated each market day.
ORMP AI Sentiment
AI sees no strong directional signal for Oramed Pharmaceuticals Inc. stock over the next 10 market days.
Prediction date: Sept. 23, 2026
Exact scores are in the SharePreds app
The precise prediction score for this stock, with buy and sell targets and a stop loss, updated every market day.
About Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.
Sector
Exchange
Market Cap
$194,259,643
Cap Tier
Employees
13
Headquarters
NEW YORK, NY
Listed Since
April 19, 2004
Website
ORMP Sentiment Trend: Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
ORMP Volatility
Oramed Pharmaceuticals Inc. has shown moderate price volatility over the last 5 trading days. Moderate volatility indicates normal market activity with typical price fluctuations.
